Puneet Souda
Stock Analyst at Leerink Partners
(3.78)
# 1,972
Out of 4,512 analysts
918
Total ratings
44.6%
Success rate
4%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Downgraded: Hold | $73 | $71.45 | +2.18% | 44 | Jun 25, 2026 | |
| NTRA Natera | Maintained: Buy | n/a | $274.73 | - | 65 | Jun 22, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $163.06 | - | 67 | Jun 2, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $35 | $26.95 | +29.87% | 1 | May 12, 2026 | |
| TWST Twist Bioscience | Upgraded: Buy | $35 → $70 | $93.50 | -25.13% | 31 | May 5, 2026 | |
| NEO NeoGenomics | Upgraded: Buy | $14 → $25 | $14.22 | +75.81% | 50 | Apr 29, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $500 → $580 | $536.53 | +8.10% | 50 | Oct 23, 2025 | |
| DHR Danaher | Reiterated: Buy | $235 | $201.67 | +16.53% | 18 | Oct 22, 2025 | |
| RVTY Revvity | Maintained: Buy | $115 → $110 | $111.69 | -1.51% | 14 | Sep 16, 2025 | |
| RGEN Repligen | Maintained: Buy | $200 | $148.05 | +35.09% | 42 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $4.07 | +47.42% | 60 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $60.08 | - | 49 | Sep 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $135.88 | +3.03% | 39 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $45.20 | -64.60% | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $58.36 | -22.89% | 40 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.13 | +370.59% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $6.18 | +45.63% | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $16 | $16.04 | -0.25% | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $8.29 | +44.75% | 40 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $378.64 | -10.20% | 38 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $23.33 | +50.05% | 48 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $190.41 | -36.98% | 81 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.40 | - | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.43 | n/a | 1 | Jun 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $6.80 | n/a | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $40.04 | n/a | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $38.20 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.41 | n/a | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $30.96 | n/a | 1 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.0007 | n/a | 9 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.000001 | n/a | 7 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $22.25 | n/a | 1 | Oct 20, 2014 |
Bio-Techne
Jun 25, 2026
Downgraded: Hold
Price Target: $73
Current: $71.45
Upside: +2.18%
Natera
Jun 22, 2026
Maintained: Buy
Price Target: n/a
Current: $274.73
Upside: -
Guardant Health
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $163.06
Upside: -
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $26.95
Upside: +29.87%
Twist Bioscience
May 5, 2026
Upgraded: Buy
Price Target: $35 → $70
Current: $93.50
Upside: -25.13%
NeoGenomics
Apr 29, 2026
Upgraded: Buy
Price Target: $14 → $25
Current: $14.22
Upside: +75.81%
Thermo Fisher Scientific
Oct 23, 2025
Reiterated: Buy
Price Target: $500 → $580
Current: $536.53
Upside: +8.10%
Danaher
Oct 22, 2025
Reiterated: Buy
Price Target: $235
Current: $201.67
Upside: +16.53%
Revvity
Sep 16, 2025
Maintained: Buy
Price Target: $115 → $110
Current: $111.69
Upside: -1.51%
Repligen
Sep 11, 2025
Maintained: Buy
Price Target: $200
Current: $148.05
Upside: +35.09%
Sep 10, 2025
Maintained: Hold
Price Target: $6
Current: $4.07
Upside: +47.42%
Sep 7, 2025
Maintained: Buy
Price Target: n/a
Current: $60.08
Upside: -
Sep 1, 2025
Maintained: Buy
Price Target: $140
Current: $135.88
Upside: +3.03%
Aug 11, 2025
Maintained: Hold
Price Target: $16
Current: $45.20
Upside: -64.60%
Aug 7, 2025
Maintained: Buy
Price Target: $45
Current: $58.36
Upside: -22.89%
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $2.13
Upside: +370.59%
Aug 6, 2025
Maintained: Hold
Price Target: $9
Current: $6.18
Upside: +45.63%
Aug 6, 2025
Upgraded: Buy
Price Target: $10 → $16
Current: $16.04
Upside: -0.25%
Aug 6, 2025
Upgraded: Buy
Price Target: $7 → $12
Current: $8.29
Upside: +44.75%
Aug 5, 2025
Reiterated: Buy
Price Target: $340
Current: $378.64
Upside: -10.20%
Aug 5, 2025
Maintained: Buy
Price Target: $35
Current: $23.33
Upside: +50.05%
Aug 1, 2025
Reiterated: Buy
Price Target: $120
Current: $190.41
Upside: -36.98%
Jul 29, 2025
Maintained: Buy
Price Target: n/a
Current: $4.40
Upside: -
Jun 1, 2025
Maintained: Buy
Price Target: n/a
Current: $2.43
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $5
Current: $6.80
Upside: n/a
May 7, 2024
Maintained: Buy
Price Target: n/a
Current: $40.04
Upside: n/a
Dec 19, 2023
Maintained: Buy
Price Target: n/a
Current: $38.20
Upside: n/a
Jun 13, 2023
Maintained: Hold
Price Target: n/a
Current: $8.41
Upside: n/a
Apr 29, 2022
Maintained: Buy
Price Target: $16
Current: $30.96
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: $3
Current: $0.0007
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Oct 20, 2014
Reiterated: Buy
Price Target: $80
Current: $22.25
Upside: n/a